Abstract
Coronary artery disease remains the most common cause of death in the United States. These events are often unexpected and fatal. African Americans and Hispanics have a greater incidence of risk factors such as type 2 diabetes, hypertension, and obesity which have all been known to increase cardiovascular risk. The Framingham Risk Score and similar ways to assess cardiac risk, often either underestimate or overestimate the risk for subsequent myocardial infarction or sudden death. Stress testing is very helpful in assessing risk in symptomatic patients but has a limited role in assessing the asymptomatic patient. Other modalities such as carotid intimal thickening, C-reactive protein, and ankle-brachial index are helpful in assessing asymptomatic patients, but they are not as powerful as coronary calcium scoring.
The purpose of this chapter is to familiarize the reader with coronary calcium scoring and its ability to identify those at higher risk. This may allow for earlier intervention prior to the occurrence of a potentially debilitating or deadly event. Furthermore, identifying those at lower risk can be accomplished with coronary calcium scoring.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Agatston AS, et al. Quantification of coronary calcium score using ultrafast computed tomography. JACC. 1990;15(4):827–8332.
Allam AH, et al. Atherosclerosis in ancient Egyptian mummies. JACC Cardiovasc Imaging. 2011;4(4):315–27. https://doi.org/10.1016/j.jcmg.2011.02.002.
Ankur G, et al. The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2017;10(8):833–42.
Bild DE, et al. Ethnic differences in coronary calcification: the multi-ethnic study of atherosclerosis (MESA). Circulation. 2005;111(10):1313–20.
Blaha MJ, Cainzos-Achirica M, Greenland P, McEvoy JW, Blankstein R, Budoff MJ, Dardari Z, Sibley CT, Burke GL, Kronmal RA, Szklo M, Blumenthal RS, Nasir K. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016;133:849–58.
Blankenhorn DH, Stern D. Calcification of the coronary arteries. Am J Roentgenol Radium Therapy, Nucl Med. 1959;81(5):772.
Budoff MJ, et al. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles. JACC. 2009a;53(4):345–52.
Budoff MJ, et al. Ethnic differences in coronary atherosclerosis. J Am Coll Cardiol. 2002;39:408–12.
Budoff MJ, McClelland RL, Nasir K, Greenland P, Kronmal RA, Kondos GT, Shea S, Lima JA, Blumenthal RS. Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2009b;158:554–61.
Budoff MJ, Raggi P, Beller GA. Noninvasive cardiovascular risk assessment of the asymptomatic diabetic patient: the Imaging Council of the American College of Cardiology. JACC Cardiovasc Imaging. 2016;9(2):176–92.
Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, Kronmal R, Lima JAC, Liu KJ, McClelland RL, Michos E, Post WS, Shea S, Watson KE, Wong ND. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J. 2018;39(25):2401–8.
Budoff MJ, et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis. 2006;187(2):343–50.
Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–45.
Doherty TM, et al. Racial differences in the significance of coronary calcium in asymptomatic black and white subjects with coronary risk factors. JACC. 1999;34(3):789–94.
Fiscella K. Racial disparity on hypertension control: tallying the death toll. Ann Fam Med. 2008;6(6):497–502.
Gepner AD, et al. Comparison of carotid plaque score and coronary artery calcium score for predicting cardiovascular disease events: the multi-EthnicStudy of atherosclerosis. J Am Heart Assoc. 2017;6:e005179. https://doi.org/10.1161/JAHA.116.005179.
Greenland P, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular disease in asymptomatic adults: a report of the ACCF/AHA Task Force on Practice Guidelines. JACC. 2010a;56(25):e50.
Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2010b;56:50–103.
Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary calcium score and cardiovascular risk. J Am Coll Cardiol. 2018;72(4):434–47.
Grundy SM, Stone NJ, Bailey AL, et al. ACC/AHA/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018a;139(25):e1082–143.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018b;2018:e1082–e1143.
Jain T, et al. Dallas heart study. J Am Coll Cardiol. 2004;44:1011–7.
Joshi PH, Blaha MJ, Budoff MJ, Miedema MD, McClelland RL, Lima JAC, Agatston AS, Blankstein R, Blumenthal RS, Nasir K. The 10-year prognostic value of zero and minimal CAC. JACC Cardiovasc Imaging. 2017;10:957–8.
Khaleeli E, Peters SR, Bobrowsky K, Oudiz RJ, Ko JY, Budoff MJ. Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: implications for management. Am Heart J. 2001;141:637–44.
Malik S, Zhao Y, Budoff M, et al. Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis. JAMA Cardiol. 2017;2:1332–40.
Mao SS, et al. Comparison of coronary artery calcium scores between electron beam computed tomography and 64-multidetector computed tomographic scanner. J Comput Assist Tomogr. 2009;33(2):175–8.
Margolis JR, et al. The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases. Radiology. 1980;137(3):609.
Miedema MD, Duprez DA, Folsom AR. The use of coronary calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis. Circ Cardiovasc Qual Outcomes. 2014;7(3):453–60.
Mielke C, Shields J, Broemeling L. Coronary artery calcium, coronary artery disease, and diabetes. Diabetes Res Clin Pract. 2001;53:55–61.
Moebus S, Stang A, Möhlenkamp S, Dragano N, Schmermund A, Slomiany U, Hoffmann B, Bauer M, Broecker-Preuss M, Mann K, Siegrist J, Erbel R, Jöckel KH, Heinz Nixdorf Recall Study Group. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort–results of the Heinz Nixdorf Recall Study. Diabetologia. 2009;52(1):81–9.
Nakanishi R, Li D, Blaha MJ, Whelton SP, Darabian S, Flores FR, Dailing C, Blumenthal RS, Nasir K, Berman DS, Budoff MJ. All-cause mortality by age and gender based on coronary artery calcium scores. Eur Heart J Cardiovasc Imaging. 2016;17(11):1305–14.
Nasir K, Bittencourt MS, Blaha MJ, Blankstein R, Agatston AS, Rivera JJ, Miemdema MD, Sibley CT, Shaw LJ, Blumenthal RS, Budoff MJ, Krumholz HM. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2015;66:1657–68.
Nasir K, Clouse M. Role of nonenhanced multidetector CT coronary artery calcium testing in asymptomatic and symptomatic individuals. Radiology. 2012;264:637–49.
Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43:1663–9.
Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Peats L, Wong ND, Rana JS, Orakzai R, Hayes SW, Friedman JD, Thomson LEJ, Polk D, Min J, Budoff MJ, Berman DS. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol. 2011a;57:1622–32.
Rozanski A, et al. Impact of CAC on coronary risk factors and downstream testing: the EISNER prospective randomized trial. J Am Coll Cardiol. 2011b;57:1622–32.
Shareghi S, Ahmadi N, Young E, Liu ST, Gopal A, Budoff MJ. The prognostic significance of zero coronary calcium scores on cardiac computed tomography. J Cardiovasc Comput Tomogr. 2007;1:155–9.
Tang W, et al. Racial differences in coronary calcium prevalence among high-risk adults. Am J Cardiol. 1995;75:1088–91.
Valenti V, Hartaigh BO, Cho I, et al. Absence of coronary artery calcium identifies asymptomatic diabetic individuals at low near-term but not long-term risk of mortality: a 15-year follow-up study of 9715 patients. Circ Cardiovasc Imaging. 2016;9:e003528.
Valenti V, Hartaigh BO, Heo R, et al. A 15-year warranty period for asymptomatic individuals without coronary artery calcium: a prospective follow-up of 9,715 individuals. JACC Cardiovasc Imaging. 2015;8:900–9.
Waheed S, et al. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: the St. Francis Heart Study. Atherosclerosis. 2016;255:193–9.
Wexler L, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications: a statement for health professionals from the American Heart Association. Writing Group. Circulation. 1996;94(5):1175–92.
Wolk MJ, et al. ACCf/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease. JACC. 2014;63(4):380–406.
Yang L, et al. Prevalence of over-weight and obesity in the United States, 2007–2012. JAMA Intern Med. 2015;175(8):1412–3.
Yeboah J, McClelland RL, Polonsky TS, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012;308:788–95.
Zheng SL, et al. Association of Aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA. 2019;321(3):277–87.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gillespie, R., Budoff, M. (2021). Coronary Calcium Scoring in African American and Hispanic Patients. In: Ferdinand, K.C., Taylor, Jr., H.A., Rodriguez, C.J. (eds) Cardiovascular Disease in Racial and Ethnic Minority Populations. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-030-81034-4_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-81034-4_15
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-81033-7
Online ISBN: 978-3-030-81034-4
eBook Packages: MedicineMedicine (R0)